BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18465169)

  • 21. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics.
    Gámez-Pozo A; Sánchez-Navarro I; Calvo E; Agulló-Ortuño MT; López-Vacas R; Díaz E; Camafeita E; Nistal M; Madero R; Espinosa E; López JA; Fresno Vara JÁ
    PLoS One; 2012; 7(3):e33752. PubMed ID: 22461895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
    Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
    Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
    J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
    Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker.
    Zhang Y; Li Y; Qiu F; Qiu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3395-401. PubMed ID: 21093387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentially expressed and activated proteins associated with non small cell lung cancer tissues.
    Nigro E; Imperlini E; Scudiero O; Monaco ML; Polito R; Mazzarella G; Orrù S; Bianco A; Daniele A
    Respir Res; 2015 Jun; 16(1):74. PubMed ID: 26104294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic biomarkers of non-small cell lung cancer patients.
    Baran K; Brzeziańska-Lasota E
    Adv Respir Med; 2021; 89(4):419-426. PubMed ID: 34494245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer.
    Du J; Yang S; Lin X; Bu L; Nan Y; Huo S; Shang W
    Diagn Pathol; 2010 Sep; 5():60. PubMed ID: 20854674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer.
    Mon MM; Srisomsap C; Chokchaichamnankit D; Watcharatanyatip K; Weeraphan C; Svasti J; Maneechai K; Thongsuksai P; Raungrut P
    Anticancer Res; 2021 Apr; 41(4):1871-1882. PubMed ID: 33813392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion.
    Gu H; Ren JM; Jia X; Levy T; Rikova K; Yang V; Lee KA; Stokes MP; Silva JC
    Mol Cell Proteomics; 2016 Feb; 15(2):692-702. PubMed ID: 26635363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
    Boccellino M; Pinto F; Ieluzzi V; Giovane A; Quagliuolo L; Fariello C; Coppola M; Carlucci A; Santini M; Ferati K; Bexheti-Ferati A; Giordano A; Di Domenico M
    J Cell Physiol; 2019 Dec; 234(12):23798-23806. PubMed ID: 31180588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma proteomics-based identification of novel biomarkers in early gastric cancer.
    Zhou B; Zhou Z; Chen Y; Deng H; Cai Y; Rao X; Yin Y; Rong L
    Clin Biochem; 2020 Feb; 76():5-10. PubMed ID: 31765635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
    Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small Extracellular Vesicles Isolated from Serum May Serve as Signal-Enhancers for the Monitoring of CNS Tumors.
    Dobra G; Bukva M; Szabo Z; Bruszel B; Harmati M; Gyukity-Sebestyen E; Jenei A; Szucs M; Horvath P; Biro T; Klekner A; Buzas K
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.